Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IBRX | BPMC | APLS | ||
| Company | Immunitybio Inc | Blueprint Medicines Corp | Apellis Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.72 | 103.88 | 46.62 | ||
| High | 8.79 | 110.00 | 47.74 | ||
| Low | 8.25 | 100.91 | 46.10 | ||
| Last | 8.45 | 106.88 | 47.06 | ||
| Change | -0.09 | +12.02 | +1.01 | ||
| % Change | -1.05% | +12.67% | +2.19% | ||
| Volume | 3,508,308 | 936,748 | 235,863 | ||
| 20-Day Average Volume | 11,694,104 | 640,754 | 1,538,919 | ||
| Previous Close | 8.54 | 94.86 | 46.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.12 | 91.24 | 50.26 | ||
| 20-Day Raw Stochastic | 64.57% | 83.83% | 47.18% | ||
| 20-Day Relative Strength | 64.34% | 66.70% | 40.16% | ||
| Weighted Alpha | +10.73 | +108.07 | -20.19 | ||
| Today's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 80% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +65.85% since 04/25/24 | +16.66% since 04/25/24 | -0.94% since 04/25/24 | ||
| Low | 4.92 on 04/26/24 | 90.47 on 04/26/24 | 38.22 on 04/30/24 | ||
| High | 10.53 on 04/29/24 | 110.00 on 05/02/24 | 50.98 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | +60.82% since 04/02/24 | +15.61% since 04/02/24 | -14.76% since 04/02/24 | ||
| Low | 4.73 on 04/12/24 | 84.33 on 04/15/24 | 38.22 on 04/30/24 | ||
| High | 10.53 on 04/29/24 | 110.00 on 05/02/24 | 58.12 on 04/04/24 | ||
| 3-Month | |||||
| %Chg | +104.71% since 02/02/24 | +33.01% since 02/02/24 | -24.10% since 02/02/24 | ||
| Low | 3.37 on 02/23/24 | 72.24 on 02/14/24 | 38.22 on 04/30/24 | ||
| High | 10.53 on 04/29/24 | 110.00 on 05/02/24 | 71.90 on 02/26/24 | ||
| 6-Month | |||||
| %Chg | +129.05% since 11/02/23 | +78.20% since 11/02/23 | -3.73% since 11/02/23 | ||
| Low | 2.66 on 11/10/23 | 56.74 on 11/13/23 | 38.22 on 04/30/24 | ||
| High | 10.53 on 04/29/24 | 110.00 on 05/02/24 | 73.80 on 01/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,781,606 | 5,805,432 | 5,585,588 | ||
| Shares Outstanding, K | 677,003 | 61,200 | 121,294 | ||
| Annual Sales | 620,000 | 249,380,000 | 396,590,000 | ||
| Annual Net Income | -583,200,000 | -506,980,000 | -528,630,000 | ||
| Last Quarter Sales | 140,000 | 71,960,000 | 146,380,000 | ||
| Last Quarter Net Income | -233,390,000 | -110,920,000 | -88,580,000 | ||
| 60-Month Beta | 1.16 | 0.65 | 0.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 03/19/24 | -1.82 on 02/15/24 | -0.73 on 02/27/24 | ||
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||